ECE2019 Poster Presentations Reproductive Endocrinology 2 (39 abstracts)
Hospital Donostia, San Sebastian, Spain.
Introduction: The presentation of new onset hyperandrogenism is extremely rare in postmenopausal women. In premenopausal women, the most common cause of androgen excess is polycystic ovary syndrome. In contrast, when hyperandrogenism develops in postmenopausal women, it is usually associated with other causes, such as ovarian hyperthecosis or an androgen secreting tumor. We describe 5 patients with hyperandrogenism (Table 1). Total Testosterone 0.060.86 ng/ml, free testosterone 212.8 ng/dl, DHEA-S 0.32.5 μg/ml, Androstendiona 0.214.5 ng/ml, FSH postmenopausal 26139 U/l, LH postmenopausal 2065 U/l, Estradiol postmenopausal <49 pg/ml, Hemoglobine 1215.3 g/dl, Hematocrite 3546%
Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | |
Age | 61 | 51 | 68 | 51 | 57 |
Ferriman Galleway | 25 | 36 | 13 | 12 | 12 |
Total testosterone | 4.41 | 3.16 | 13.2 | 6.9 | 0.68 |
Free testosterone | 86.2 | 64.2 | 160.9 | 190.2 | 16.1 |
DHEA-S | 0.61 | 1.71 | 0.34 | 55.2 | 1.63 |
Androstenodione | 2.1 | 3.6 | 2.4 | 10 | 3.9 |
FSH/LH | 61.8/20.1 | 23.5/19.1 | 52.6/40.6 | 31.9/14.5 | 31.9/18.5 |
Estrogen | 25.7 | 29.5 | 31.9 | 50.2 | 13.4 |
Nugent | 0.9 | 1.1 | 1.2 | 26 | 1.2 |
Hb/Hemotocrite | 17.3/51.4 | 17.8/52.1 | 16.1/48.9 | 16/47.2 | 13.1/41.4 |
Ovaric US | Normal | Normal | Tumor in Right ovary | Normal | Bilateral Solid tumor |
Adrenal TC | Bilateral Adenoma | Bilateral Adenoma | Normal | Adrenal Carcinoma | Normal |
Surgery | Bilateral Oophorectomy | Bilateral Oophorectomy | Bilateral Oophorectomy | Unresectable | Bilateral Oophorectomy |
AP | Leydig Tumor | Leydig Tumor | Leydig Tumor | Hyperthecosis | |
Normalization Androgenism | Yes | Yes | Yes | No | Yes |
Conclusion: Diagnosing the source of hyperandrogenism in postmenopausal women remains a clinical challenge. In post menopausal women with progressive hirsutism or virilization, it may be reasonable to consider bilateral oopherectomy in the setting of normal ovarian imaging and biochemical evidence of ovarian source of the hyperandrogenism. The combination of a detailed history, proper clinical assessment and appropriate laboratory and imaging evaluation is required for the accurate differential diagnosis and management.